Featured Participant and Panelist Details
A
Myoung-Ock AHN, M.D., Ph.D., M.P.H. – Member, National Assembly of the Republic of Korea
Myoung-Ock Ahn is a Member of Parliament in the Republic of Korea’s National
Assembly of the Republic of Korea. She is also President and Chairman of the International Korean
Medical Organization, a member of the Gender Equality and Family Committee, and an executive
member of the Korean Parliamentarian League on Children, Population, and Environment. Dr. Ahn
also serves as Head of the Low Fertility and Aging Task Force of the GNP. She is formerly a Professor
in the School of Public Health at Pocheon Jungmun University.
Top |
Back
Peter ANDREWS, Ph.D. – Chief Scientist, Queensland Government, Australia (Attended Summit 2005)
In 2003, Peter Andrews was appointed as the first Queensland Chief Scientist, and he has since worked to raise the state's profile on the national and international stage as a center of research and commercialization. He is an eminent Australian scientist and bio-entrepreneur and has been at the forefront of initiatives to develop the Australian biotechnology industry. Dr. Andrews is an active advocate of the commercialization of Australian science, research, and innovation.
Top |
Back
B
Huqun BAI – Deputy Director-General, Bureau of Disease Prevention and Control, Ministry of Health, China (Attended Summit 2007)
Huqun Bai is Deputy Director-General of the Bureau of Disease Prevention and Control at the Ministry of Health in China. Previously, he served as Vice President and Associate Researcher at the Chinese CDC and at the Chinese Academy of Preventative Medicine. Prior to serving in these positions, Mr. Bai held several posts at the Ministry of Health, including Director of the Division of General Affairs and Coordination in the Department of Health Supervision.
Top |
Back
Anna BARKER, Ph.D. – Deputy Director, Strategic Scientific Initiatives, National Cancer Institute (Attended Summits 2005 & 2006 , Confirmed for 2008)
Dr. Barker is the Deputy Director of the National Cancer Institute. In this position she develops
and implements programs to specifically accelerate the movement of laboratory discoveries
through development into new interventions to prevent, detect, and treat cancer. Trained in immunology
and microbiology, her research interests include experimental therapeutics, tumor immunology,
and free-radical biochemistry in cancer etiology and treatment.
Top |
Back
Andrew BERLIN, Ph.D. – Director, Biomedical and Life Sciences, Intel Corporation (Attended Summit 2005)
Dr. Andrew Berlin manages Intel Corporation's newly formed Biomedical and Life Sciences business within the Intel Digital Health Group. Dr. Berlin has served on the board of directors of the MEMS Industry Association and on a variety of advisory boards in the biotechnology and microsystems fields. Dr. Berlin holds 32 US patents and dozens of international patents in the areas of MEMS and Microsystems.
Top |
Back
Alan BERNSTEIN, Ph.D. – President, Canadian Institutes of Health Research (Attended Summit 2005)
Alan Bernstein is President of the Canadian Institutes of Health Research, Canada's lead agency for the support of health research, and a Senior Fellow at the University of Toronto. An internationally respected researcher and scientific leader, his research is central to the study of embryonic development, hematopoiesis, and cancer. Previously, he was Director of Research at the S. Lunenfeld Research Institute and Professor of Molecular and Medical Genetics at the University of Toronto.
Top |
Back
William BRODY, M.D., Ph.D. – President, The Johns Hopkins University (Attended Summit 2006)
William Brody became the 13th president of The Johns Hopkins University on September 1, 1996. Immediately prior to assuming the position, Dr. Brody was the provost of the Academic Health Center at the University of Minnesota. From 1987 to 1994, he was the Martin Donner Professor and director of the Department of Radiology, professor of electrical and computer engineering, and professor of biomedical engineering at Johns Hopkins, and radiologist- in-chief of The Johns Hopkins Hospital.
Top |
Back
Louis J. BURNS – Vice President and General Manager, Digital Health Group, Intel (Attended Summit 2005)
Louis Burns is Vice President and General Manager of Intel's newly formed Digital Health Group. The development of this group reflects a sharpened focus on solutions for healthcare research, diagnostics and productivity, and personal healthcare. Under his leadership, Intel continues its Precision Biology research with the goal of creating fundamental advances in sensor technology for the diagnoses of disease and improvement of health through the use of microchips. He also oversees Intel's Proactive Health research to explore the ways in which ubiquitous computing can support the daily health and wellness needs of people in their homes and everyday lives through a context-aware, wireless sensor network system for the home.
Prior to his current role in Digital Health, Louis Burns held positions as the general manager of the Intel Desktop Platforms Group (DPG), and vice president and general manager of the Platform Components Group. Burns also served as vice president and director of Intel’s Information Technology group for four years.
Top |
Back
Steven BURRILL – CEO, Burrill & Company (Attended Summit 2005)
Steven Burrill is CEO of Burrill & Company, a life sciences merchant bank. He is an early pioneer in the biotechnology industry and has helped establish and support life sciences companies for 35 years. He is Chairman of the Boards at Icoria, Pharmasset, and Pyxis Genomics, and serves on the boards at Catalyst Biosciences, Depomed, Targacept, and Third Wave Technologies. The editors at Scientific American recognized him as a biotechnology investment visionary in 2002.
Top |
Back
C
Hongxin CAO, M.D. – President, Academy of Chinese Medical Sciences (Attended Summit 2006)
Hongxin Cao is the President of the Academy of Chinese Medical Sciences in Beijing.
Top |
Back
William CASTELL – Chairman, The Wellcome Trust (Attended Summits 2005 & 2007, Confirmed for 2008)
On January 1, 2006, Sir William Castell was appointed Chairman of the The Wellcome Trust. Since 2004, William Castell had served as the President and CEO of GE Healthcare, a $14-billion dollar global company. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer’s and cardiovascular diseases. Sir William Castell was knighted by Queen Elizabeth II for contributions to the life sciences industry and royal family after serving as the appointed chairman of the Prince’s Trust, a charity set up by the Prince of Wales.
Top |
Back
Maria CATTAUI – Member, Board of Directors, Petroplus Holdings; Former Secretary-General, International Chamber of Commerce (Attended Summits 2005, 2006, & 2007)
Maria Livanos Cattaui is a Member of the Board of Directors for Petroplus Holdings. Previously, Ms. Cattaui served as Secretary-General of the International Chamber of Commerce (ICC) from 1996-2005. Prior to joining ICC, she was the Managing Director of the World Economic Forum and organized its annual meeting in Davos, Switzerland.
Top |
Back
Margaret CHAN, M.D. - Director-General, World Health Organization (Attended Summit 2007, Confirmed for 2008)
Margaret Chan, MD, is Director-General of the World Health Organization, where she has also served as Assistant Director-General for Communicable Diseases, Director of Communicable Diseases Surveillance and Response, Representative to the Director-General for Pandemic Influenza, and Director of the Department for Protection of the Human Environment. Previously, she was Director of the Hong Kong Department of Health.
Top |
Back
Ding-Shinn CHEN, M.D. - Chairman, Taiwan Hepatitis Control Committee and Dean, College of Medicine, National Taiwan University (Attended Summits 2005 & 2006)
Ding-Shinn Chen is Chairman of the Taiwan Hepatitis Control Committee, and Dean of the College of Medicine at National Taiwan University. His specializations are internal medicine and gastroenterology, and his field of interest is viral hepatitis and liver disease. Dr. Chen serves on editorial boards for numerous international journals, including the Journal of Hepatology.
Top |
Back
Zhu CHEN, M.D., Ph.D. - Vice President and Member, Chinese Academy of Sciences (Attended Summit 2005 & 2007)
Zhu Chen, PhD, is Vice President and Member of the Chinese Academy of Sciences and Director of the Chinese Human Genome Center in Shanghai. Dr. Chen is also Director of the Shanghai Institute of Hematology and a Professor at Shanghai Rui Jin Hospital. He is a member of several international scientific organizations and has received many awards, including the French Chevalier de l’Ordre National de la Légion d’Honneur.
Top |
Back
May Tsung-Mei CHENG - Host, International Forum, International Center, Princeton University (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
May C. Reinhardt is host of International Forum, a Princeton University television program on international affairs. The program focuses on analyses of a wide variety of current political, economic and social issues around the globe. Featured guests include national political leaders, diplomats, government bureaucrats, members of parliament, activists as well as Princeton University faculty and visiting scholars. An expert on health policy and quality assurance, she has lectured on these topics at conferences in the U.S., Germany, the Vatican, Taiwan, and Mexico. She is the co-founder of the Princeton Conference, an annual national conference on health policy that unites the U.S. Congress, government and the research community on issues affecting health care in America.
Top |
Back
Yung-chi CHENG, Ph.D. - Henry Bronson Professor of Pharmacology, Yale University (Attended Summits 2005 & 2006)
Yung-Chi Cheng, is the Henry Bronson Professor of Pharmacology at the Yale University School of Medicine, specializing in cancer and viral chemotherapy. He is also Distinguished Visiting Scientist to the University of Hong Kong. Dr. Cheng’s career has focused primarily on experimental therapeutics as well as exploring the role of Traditional Chinese Medicine for current clinical use. In December of 2003, with the assistance of the University of Hong Kong, he organized the “Consortium for Globalization of Chinese Medicine.”
Top |
Back
William CLARKE, M.D. – President and CEO, Cellectar, LLC (Attended Summits 2005, 2006, & 2007)
William Clarke, M.D., is President and CEO of Cellectar, LLC. Prior to joining Cellectar, he served as Executive Vice President and Chief Technology & Medical Officer of GE Healthcare, a position he was appointed to in April 2004. Previously, he oversaw the Global Research, Development, Medical, and Regulatory functions as Executive Vice President of R&D, Amersham Health. He also is actively involved in a number of United States health policy issues. Before joining Amersham in December 2000, Dr. Clarke spent three years as Director of Biological Sciences at Glaxo Wellcome U.K. with responsibility for pre-clinical disease-focused biological research. Before joining the pharmaceutical industry, he held a number of academic positions, most recently as Associate Professor at the Department of Anesthesiology/Critical Care Medicine and Pediatrics at the University of Washington School of Medicine.
Top |
Back
Lawrence COREY, M.D. – Joint head, Fred Hutchinson Cancer Research Center Clinical Research Division's Program in Infectious Diseases and Virology Division of the University of Washington's Department of Laboratory Medicine (Attended Summit 2006 & 2007)
Dr. Corey serves as the joint head of the Fred Hutchinson Cancer Research Center Clinical Research Division's Program in Infectious Diseases and the Virology Division of the University of Washington's Department of Laboratory Medicine. Dr. Corey specializes in herpesvirus, HIV and other infectious disease-related research
Top |
Back
Molly COYE, M.D., M.P.H. – CEO, Health Technology Center (Attended Summit 2005)
Molly Coye, M.D., M.P.H., is the founder of the Health Technology Center, a non-profit organization dedicated to advancing the use of beneficial technologies for healthier people and communities. Coye is a member of the Institute of Medicine and in 2003 was named “Woman of the Year” by the Women Health Care Executives of Northern California.
Top |
Back
Nigel CRISP – Advisor, Global Health Workforce Alliance (Attended Summit 2006 & 2007, Confirmed for 2008)
Lord Nigel Crisp is a British former senior civil servant in the NHS, who was awarded a life peerage upon retirement. He was appointed as Chief Executive of the NHS and Permanent Secretary at the Department of Health in November 2000, and retired in March 2006. Lord Crisp first joined the NHS in 1986 from a background in community work, and then became the General Manager for Learning Disabilities and moved in 1988 to become General Manager (and later Chief Executive) of Heatherwood and Wexham Park Hospitals. He became Chief Executive of the Oxford Radcliffe Hospitals NHS Trust in 1993. Lord Crisp became South Thames Regional Director of the NHS Executive in February 1997 and London Regional Director in January 1999. He was appointed Knight Commander of the Order of the Bath (KCB) in the New Years Honours 2003.
Top |
Back
D
Nils DAULAIRE, M.D. – President and CEO, Global Health Council (Attended Summit 2007)
Nils Daulaire is President and CEO of the Global Health Council. Prior to assuming this position, Dr. Daulaire was the senior health advisor at USAID. Earlier, he worked for 15 years in primary health programs in Asia, Africa, and Latin America, and carried out field research on child survival. Dr. Daulaire is board certified in preventive medicine and public health.
Top |
Back
Sally DAVIES, M.D. – Director of Research and Development, UK Department of Health (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
Sally Davies is Director of Research and Development for the UK Department of Health, having been Deputy Director since 2003 and Director of R&D for NHS in London Region from 1996. She holds a personal Chair in Haemoglobinopathies at Imperial College Faculty of Medicine and is Co-Chair for the Department of Health on the Clinical Research Working Group following the PICTF report, responsible for developing strategies to improve the NHS research pharma partnership and outcomes. She was a member of the recent Biotechnology Innovation and Growth Team and the Healthcare Industries Taskforce.
Top |
Back
Eric DISHMAN – General Manager, Consumer Health Platforms, Intel Corporation and Principal Research Scientist, Intel Corporation (Attended Summit 2005)
Eric Dishman is General Manager and founder of Intel’s Consumer Health Platforms Group as part of Intel’s newly formed Digital Health Group. He is responsible for new business development, research, and corporate strategy for consumer-oriented healthcare technologies. He directs Intel's Proactive Health Research lab focused on home health technologies for seniors and their families who are struggling with cognitive decline, cancer, and cardiovascular disease. He is also the Chair of the Intel Research Council Health Subcommittee, which funds university grants on consumer health & wellness technologies. In partnership with the American Association of Homes and Services for the Aging (www.aahsa.org), Eric founded and serves as the national Chair of the Center for Aging Services Technologies (www.agingtech.org), a cross-industry working group that is driving technology R&D to help seniors—and the people who care for them— to live long and live well no matter where they choose to live. In partnership with the national office of the Alzheimer’s Association, Eric co-founded a new research consortium called ETAC (Everyday Technologies for Alzheimer’s Care) at http://www.alz.org/research/care/.
Top |
Back
Esther DYSON – Editor, Release 1.0 (Attended Summit 2006)
Esther Dyson is editor at large at CNET Networks, where she is responsible for its monthly newsletter, Release 1.0, and its PC Forum, the high-tech market's leading annual executive conference. As editor at large, she also contributes insight and content to CNET Networks' other properties. She sold her business, EDventure Holdings, to CNET Networks in early 2004. Previously, she had co-owned EDventure and written/edited Release 1.0 since 1983.
Top |
Back
Victor DZAU, M.D. – Chancellor, Duke University Medical Center & Health System (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
Victor J. Dzau is Chancellor for Health Affairs at Duke University and President and CEO of the Duke University Health System. He is also James B. Duke Professor of Medicine, and Director of Molecular and Genomic Vascular Biology. He had previously served as Hersey Professor and chairman of Medicine at Harvard Medical School, and chairman of the Department of Medicine at Stanford.
Top |
Back
E
Christopher J. ELIAS, M.D., Ph.D. – President, PATH (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
As president of PATH, an international, nonprofit, nongovernmental organization, Dr. Elias is responsible for all strategic, programmatic, financial, and management operations. Based in Seattle, PATH has 18 offices in 12 countries and currently works in more than 100 countries in the areas of reproductive health; vaccines and immunization; HIV, AIDS, and tuberculosis; and children’s health and nutrition. Prior to joining PATH, Dr. Elias was a Senior Associate in the International Programs Division of the Population Council. For six years, he served as the Country Representative in Thailand, where he managed reproductive health programs throughout Southeast Asia.
Top |
Back
F
Hengshan FAN, Ph.D. – Director General, Department of Economic System Reform, China's National Development and Reform Committee (Attended Summit 2006)
Hengshan Fan is Director General of the Department of Economic System Reform in China's National Development and Reform Committee.
Top |
Back
Julio FRENK, M.D., Ph.D., M.P.H. – Senior Fellow, Bill & Melinda Gates Foundation (Attended Summit 2007)
Julio Frenk, MD, PhD, MPH, is Senior Fellow at the Bill & Melinda Gates Foundation where he counsels on global health issues and strategies. Prior to this, he served for six years as Minister of Health of Mexico, where he led an ambitious reform to provide universal health insurance. Dr. Frenk has held many executive positions at the WHO and the Mexican Health Foundation, and was the founding Director-General of the National Institute of Public Health of Mexico.
Top |
Back
Stephen H. FRIEND, M.D., Ph.D. – Executive Vice President, Oncology and Advanced Technologies, Merck and Co. Inc. (Attended Summit 2005)
Stephen Friend, MD, PhD, has been Executive Vice President and led advanced technologies and oncology research for Merck since 2005. He joined Merck in 2001 as Vice President of Basic Research after Merck acquired Rosetta Inpharmatics, where he has been President since 1997. Using his unique experience with gene-expression technology, Dr. Friend and his team are applying new approaches to help accelerate cancer drug discovery and development at Merck.
Top |
Back
G
Top |
Back
Laurie GARRETT – Senior Fellow for Global Health, Council on Foreign Relations (Attended Summit 2007)
Laurie Garrett is Senior Fellow for Global Health at the Council on Foreign Relations. She is an expert on global health with a particular focus on newly emerging and re-emerging diseases and their effects on foreign policy and national security. Her writing has appeared in Foreign Affairs, Esquire, Vanity Fair, The Washington Post, and other publications. She has received several prestigious awards for journalism including The Peabody, The Polk (twice), and The Pulitzer.
Top |
Back
William H. GATES, Sr. – Co-Chair, Bill & Melinda Gates Foundation (Attended Summits 2005, 2006, & 2007)
William H. Gates, Sr. is Co-Chair of the Bill and Melinda Gates Foundation. He is founding Partner at Preston Gates & Ellis and has been President of the King County Bar Association and the Washington State Bar Association. He founded the Technology Alliance, is a Regent of the University of Washington, and is involved in numerous Northwest organizations, including the Greater Seattle Chamber of Commerce and King County United Way.
Top |
Back
Bruce GELLIN, M.D., M.P.H. – Director, National Vaccine Program, U.S. Department of Health and Human Services (Attended Summit 2007)
Bruce G. Gellin, M.D., M.P.H., is Director of the National Vaccine Program and Chair of the Secretary’s Task Force on Influenza Preparedness at the U.S. Department of Health and Human Services. He is a leading expert on vaccines and infectious diseases in the United States. Previously, he was Director of the National Network for Immunization Information, has held positions at U.S. NIH, U.S. CDC, and The Rockefeller Foundation, and is a regular consultant to the WHO.
Top |
Back
Vartan GREGORIAN, Ph.D. – President, Carnegie Corporation (Attended Summit 2006)
Vartan Gregorian is the twelfth president of the Carnegie Corporation of New York. Prior to his current position, which he assumed in June 1997, Gregorian served for nine years as the sixteenth president of Brown University. Gregorian has taught European and Middle Eastern history at San Francisco State College, the University of California at Los Angeles, and the University of Texas at Austin. In 1972 he joined the University of Pennsylvania faculty and was appointed Tarzian Professor of History and professor of South Asian history. He was founding dean of the Faculty of Arts and Sciences at the University of Pennsylvania in 1974 and four years later became its twenty-third provost until 1981.
Top |
Back
Jessie GRUMAN, Ph.D. – President and Executive Director, Center for the Advancement of Health (Attended Summit 2006)
Jessie Gruman is the President of the Center for the Advancement of Health. She is a specialist in adherence to therapies, behavioral interventions, community participation and mobilization, development of guidelines, development of information, education and communication materials (including training), disease management, health legislation and regulation, and integrated care, for chronic conditions in general.
Top |
Back
H
Lee HARTWELL, Ph.D. - President and Director, Fred Hutchinson Cancer Research Center (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
Dr. Hartwell's current interests focus on improving molecular diagnostics to identify individuals at high risk for cancer, detect the disease at an early stage when it can be cured, provide prognostic information and monitor therapeutic response. He is involved in national and international projects to improve proteomic technology for biomarker discovery through large team science. Dr. Hartwell has received many national and international scientific awards, including the 2001 Nobel Prize in Physiology or Medicine, the Lasker Basic Medical Research Award, the Gairdner Foundation International Award, and the Alfred P. Sloan Award in Cancer Research. He is a member of the National Academy of Sciences.
Top |
Back
William HASELTINE, Ph.D. - President, William A. Haseltine Foundation for Medical Sciences and the Arts (Attended Summit 2006)
William Haseltine is President of the William A. Haseltine Foundation for Medical Sciences and the Arts. He is also a professor at The Scripps Research Institute and sits on the board for the Institute for One World Health. In 1992, he founded Human Genome Sciences, serving as its chairman and CEO until October 2004. A Harvard University faculty member from 1976-1993, he created and served as chair of two academic departments at the Dana Farber Cancer Institute. Haseltine founded The Journal of AIDS Research and Retrovirology
and The Journal of Regenerative Medicine and has received
numerous awards and honors for his research on cancer, AIDS, and
biotechnology. His active business career includes establishing
seven biotechnology companies and participating in the formation
of another 20.
Top |
Back
David HEYMANN, M.D. - Assistant Director-General, Communicable Diseases and Representative of the Director-General for Polio Eradication, WHO (Attended Summit 2007)
Dr. David L. Heymann is Assistant Director-General for Communicable Diseases and Representative of the Director-General for Polio Eradication at the WHO. He has held several senior positions at the WHO and worked for thirteen years as a medical epidemiologist in sub-Saharan Africa for the U.S. CDC. Dr. Heymann has published extensively and is a recipient of the American Public Health Association Award for Excellence, among other awards.
Top |
Back
J. Edward HILL, M.D. - President, American Medical Association (Attended Summits 2005 & 2006)
J. Edward Hill, MD, is President of the American Medical Association and was elected Chairman of the Board of Trustees in 2002. He is a leading rural family medicine doctor and directed a maternal child health program in Mississippi that lowered the fetal mortality rate from one of the highest in the United States to below the national average. He teaches at North Mississippi Medical Center, the nation's largest rural hospital, where he earlier directed the Family Practice Residency Program.
Top |
Back
Joeseph HOGAN – President and CEO, GE Healthcare (Attended Summit 2007)
Joseph M. Hogan is President and Chief Executive Officer of GE Healthcare Technologies, the global leader in medical diagnostic technology and information systems. Previously, Hogan served as Executive Vice President and Chief Operating Officer of GE Medical Systems. In March 1998, he was named President and Chief Executive Officer of GE Fanuc Automation North America, Inc., a global supplier of industrial controls systems, a joint venture between GE and FANUC, Ltd. Japan. Hogan joined GE Medical Systems in April 2000 as Vice President of Global eBusiness, a role that was expanded in June 2000.
Top |
Back
Lee HOOD, M.D., Ph.D. – President, Institute for Systems Biology (Attended Summits 2005, 2006, & 2007)
Dr. Hood’s research has focused on the study of molecular immunology, biotechnology, and genomics. His professional career began at Caltech where he and his colleagues pioneered four instruments—including the DNA sequencer which played a crucial role in contributing to the successful mapping of the human genome. In 1992, he moved to the University of Washington as founder and Chairman of the Department of Molecular Biotechnology. In 2000, he co-founded the Institute for Systems Biology to pioneer systems approaches to biology and medicine. His lifelong contributions to biotechnology have earned him the prestigious 2003 Lemelson–MIT Prize, the 2002 Kyoto Prize and the 1987 Lasker Prize. Dr. Hood has also co-founded numerous biotechnology companies, including Amgen and Applied Biosystems.
Top |
Back
I
John IGLEHART – Founding Editor, Health Affairs (Attended Summits 2005 & 2006)
Since 1981, John Iglehart has been Editor of Health Affairs. During this same period, Mr. Iglehart also served as national correspondent for the New England Journal of Medicine, for which he wrote more than 100 essays called Health Policy Report. Before 1981, Mr. Iglehart was a vice president of the Kaiser Foundation Health Plan and director of its Washington, D.C. office. During the decade 1969 to 1979, he held a variety of editorial positions, including the editorship at the National Journal, a privately published weekly on federal policymaking. Mr. Iglehart was elected to membership in the Institute of Medicine of the National Academy of Sciences in 1977 and served on its Governing Council for six years (1985-1991). He also is an elected member of the National Academy of Social Insurance.
Top |
Back
Naoki IKEGAMI – Chair, Health Policy, Keio University (Attended Summits 2005 & 2006)
Naoki Ikegami is Professor and Chair of the Department of Health Policy and Management at the Keio School of Medicine. His research areas are health policy, long-term care and pharmacoeconomics. During 1990-1991, Dr. Ikegami was a visiting professor at the University of Pennsylvania's Wharton School and Medical School, and has continued to be a Senior Fellow at the Wharton. He is a board member of interRAI (a non-profit international consortium of researchers and clinicians focused on care planning instruments), Priorities in Health Care, and the Japanese Society on Hospital Administration. He has served as consultant to the WHO and the World Bank, and has also sat on various national and state government committees.
Top |
Back
J
Zuojun JIANG, M.D. – Vice Minister, Ministry of Health, China (Attended Summit 2006)
Zuojin Jiang is China's Vice Minister of Health. He was a professor of medicine at the Anhui Institute of Medicine since the late 1980s and has been active in the China Zhi Gong Dang since the early 1990s, serving as a member of its National Standing Committee and chairman of its Anhui Provincial Committee.
Top |
Back
K
Gary KAPLAN, M.D. – Chairman and CEO, Virginia Mason Medical Center (Attended Summits 2005 & 2006)
In 2000, Gary Kaplan, M.D. was named Chairman and CEO of Virginia Mason Medical Center, where he has practiced Internal Medicine since 1982. He is a fellow of the American College of Physicians and a clinical professor at the University of Washington. Dr. Kaplan serves on the MGMA Services Board, and the Board of Directors and Executive Committee of the National Patient Safety Foundation.
Top |
Back
Choon-Jin KIM, Ph.D. – Member, National Assembly of the Republic of Korea (Attended Summits 2006 & 2007)
Dr. Kim is a Member of Korea's National Assembly.
Top |
Back
Ann Marie KIMBALL, M.D., M.P.H. – Director, APEC Emerging Infections Network, University of Washington (Attended Summits 2005, 2006, & 2007)
Ann Marie Kimball, M.D., M.P.H., is Director of the APEC Emerging Infections Network, and Professor
of Public Health and Medicine at the University of Washington. Her book, Risky Trade, Infectious
Disease in the Era of Modern Trade, was published in 2006. In 2004, Dr. Kimball received a Guggenheim
Foundation Fellowship Award for her work on trade and emerging infections. Dr. Kimball
has worked for the WHO (PAHO) and the National Alliance of State and Territorial AIDS Directors
to address HIV.
Top |
Back
Richard KLAUSNER, M.D. – Chairman, The Column Group (Attended Summit 2005)
Richard Klausner, M.D., is Chairman of The Column Group, a biotech venture capital fund. As an expert in global health, Dr. Klausner previously served as Executive Director of Global Health at the Bill & Melinda Gates Foundation. Dr. Klausner is an expert in cellular and molecular biology and has received a wide variety of honors, including the Outstanding Investigator Award from the American Federation of Clinical Research. He has served as senior fellow at the National Academies of Science, a long time advisor to the Presidents of the Academies for counter-terrorism and a liaison to the White House Office of Science & Technology Policy.
Top |
Back
Robert KOLODNER, M.D. – National Coordinator for Health Information Technology, U.S. Department of Health and Human Services (Attended Summit 2007)
Robert M. Kolodner, MD, is National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, a post which he was appointed to in April 2007. Previously, he served as Chief Health Informatics Officer for Veterans Health Administration in the U.S. Department of Veterans Affairs (VA) where he was instrumental in the development and oversight of VistA, the VA’s electronic health records systems, and My HealtheVet, the VA’s Personal Health Record for veterans.
Top |
Back
Caroline KOVAC, Ph.D. – General Manager, IBM Healthcare and Life Sciences (Attended Summits 2005 & 2006)
Caroline Kovac is responsible for the strategic direction of IBM’s global healthcare and life sciences business. She leads her team in developing the latest information technology solutions and services, establishing partnerships and overseeing IBM investment within the healthcare, pharmaceutical and life sciences markets. Carol sits on the Board of Directors of Research!America, Africa Harvest and the Johns Hopkins University School of Nursing Advisory Council. In 2004, Carol had the distinction of being named one of the 50 most powerful women in business by Fortune magazine.
Top |
Back
Kiyoshi KUROKAWA, M.D. – Science Advisor to the Cabinet for Science and Technology and Chairman of Health Policy Institute (Attended Summits 2005 & 2006, Confirmed for 2008)
Kiyoshi Kurokawa is the Science Advisor to the Japan's Prime Minister. Previously, he served as Director of the Institute of Medicine of Medical Sciences at Tokai University in Japan and Professor Emeritus at the University of Tokyo. In addition to his academic duties, Dr. Kurokawa serves as member of the Association of American Physicians and the American Society for Clinical Investigation. He is former president of the Japanese Society of Internal Medicine and the International Society of Nephrology in Japan and has served on committees in the Ministries of Japan. In 1999, Dr. Kurokawa was awarded the Order of Purple from the Government of Japan for excellence in academic achievements.
Top |
Back
L
David LAWRENCE, M.D. – Former Chairman & CEO, Kaiser Permanente (Attended Summits 2005 & 2006)
David M. Lawrence, M.D., was named Chief Executive Officer of Kaiser Permanente in 1991 and Chairman of the Boards of Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals in 1992. Dr. Lawrence retired in May, 2002. Dr. Lawrence currently serves on the Boards of Agilent Technologies, Pacific Gas and Electric Corporation, Raffles Medical Group of Singapore, McKesson Corporation, and the RAND Health Advisory Board, among others. He also serves in advisory roles to the biotechnology industry.
Top |
Back
Jong-Wook LEE, M.D. – Former Director-General, World Health Organization (Attended Summit 2005)
Jong-wook Lee, M.D., was the Director-General of the World Health Organization from July 2003 until his passing on May 22, 2006. Prior to taking up the post of Director-General, he led global tuberculosis control activities and polio eradication in the Western Pacific Region. Dr. Lee was from the Republic of Korea.
Top |
Back
Kyeong-Ho LEE, Ph.D. – President, Korea Health Industry Development Institute (Attended Summits 2005 & 2006)
Kyeong-Ho Lee, Ph.D. in Public Health, has been president of the Korea Health Industry Development Institute in the Republic of Korea, since 2003. He is former Vice-Minister of the Ministry of Health and Welfare (MoHW) of Korea, and for thirty years has served as government officer at the MoHW. With wide experience in the field of health policy and administration, he also gave lectures at Yonsei Univ. and Inje Univ. In December 2000, Dr. Lee was awarded the Order of Yellow from the Korean Government.
Top |
Back
Shichuo LI, M.D. – President, Chinese Association Against Epilepsy (Attended Summit 2005)
Shichuo Li is President of the Chinese Association Against Epilepsy, Senior Advisor to the Department of International Cooperation under the Chinese Ministry of Health, and Director of the Beijing COCE Epilepsy and Encephalopathy Hospital. Between 1998 and 2003, he held various positions with WHO, including WHO Representative in the South Pacific, Special Advisor to the Director-General, and Assistant Director-General.
Top |
Back
Shouxin LI, Ph.D. – Director-General, Department of Social Development, China's National Development and Reform Commission (Attended Summit 2006)
Shouxin Li is Director-General of the Department of Social Development in China's National Development and Reform Commission.
Top |
Back
Depei LIU, Ph.D. – Vice President, Chinese Academy of Engineering and President, Chinese Academy of Medical Sciences (Attended Summits 2005, 2006, & 2007)
Depei Liu is Vice President of the Chinese Academy of Engineering, President of the Chinese Academy of Medical Sciences, and President of Peking Union Medical College. In 2002, he received the top Chinese medical science and technology award. Dr. Liu's specialization is gene regulation of expression and gene therapy, and his research focuses on gene regulation of expression in differentiation and development, transgenic animals and disease models, gene transfer, and gene therapy.
Top |
Back
Edison LIU, M.D. – Executive Director, Genome Institute of Singapore (GIS) (Attended Summit 2005)
In 2001, Edison Liu, M.D., assumed the position of executive director at the Genome Institute of Singapore which is a flagship program of the Biomedical Sciences Initiative of Singapore. At the GIS, he is building an international collaboration of 300 individuals focused on integrating genomic sciences with cell and medical biology. His current individual research focuses on the genome-wide transcriptional control by nuclear hormone receptors in cancer biology.
Top |
Back
Peter LOESCHER – President and CEO, GE Healthcare Bio-Sciences (Attended Summits 2005 & 2006)
Peter Loescher was appointed President and CEO of GE Healthcare Bio-Sciences in April 2004. In this role, Peter oversees the Medical Diagnostics, Discovery Systems, and Protein Separation businesses that make up the Bio-Sciences division of GE Healthcare. Previously, Loescher was appointed as the Chief Operating Officer of Amersham plc in 2004, having responsibility for global operations across all Amersham businesses. Loescher joined Amersham plc in 2002 as President, Amersham Health, and a member of the Board of Directors. Prior to Amersham, Loescher served more than 16 years in senior management roles in the pharmaceutical industry, including a position as the President and Chief Executive Officer of Aventis Pharma Japan from 1999 until 2002. In his last two years in that role, Loescher also served as Chairman of Aventis Pharma Japan’s Board of Directors. Previously, Loescher held a variety of international leadership roles at Hoechst, Aventis’ predecessor, which he joined in 1988.
Top |
Back
M
Craig MUNDIE – Chief Research and Strategy Officer, Microsoft (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
Craig Mundie is Senior Vice President and Chief Technical Officer of Advanced Strategies and Policy at Microsoft. Mr. Mundie works on developing comprehensive technical, business, and policy strategies, including internet-scale platform architectures, critical infrastructure protection, technology regulation, and developing local software economies. Until 1992, he was CEO of Alliant Computer Systems Corporation, which he co-founded. In 2000, President Clinton named Mr. Mundie to the National Security Telecommunications Advisory Committee and since 2002, he has served on the Council on Foreign Relations. Mr. Mundie is a trustee of the Fred Hutchinson Cancer Research Center in Seattle and on the advisory board of the College of Computing at the Georgia Institute of Technology.
Top |
Back
N
David NABARRO, Ph.D. – Senior United Nations System Coordinator for Avian and Human Influenza (Attended Summit 2006 & 2007)
David Nabarro, Ph.D., is Executive Director of Sustainable Development and Healthy Environments, a department under the World Health Organization. He is also the Senior Policy Advisor to the Director General of the WHO and Head of its Crisis Management Team. He joined the WHO in 1999 as Project Manager for the RollBack Malaria Program, then moved to the Office of the Director-General, as Executive Director in 2000. David Nabarro qualified as a physician in 1973, then worked in the UK National Health Service. He was also Chief Health and Population Adviser, at the Overseas Development Organization (ODA) London Office in 1990, and moved on to become Director of Human Development (as well as Chief Health Adviser) as ODA was transformed to the Department for International Development in 1997.
Top |
Back
Jay NAIDOO – Chairman of the Board, Global Alliance for Improved Nutrition (GAIN)
Jay Naidoo is Chairman of the Board of the Global Alliance for Improved Nutrition (GAIN). He is also Chair of the Johnson & Johnson Development Trust, the social development arm of the Johnson & Johnson Group, and the Development Bank of Southern Africa, a key financial institution driving the expansion of social and economic infrastructure in the Southern African Development Community (SADC) region. Previously, he served as Minister of the Research and Development Program in the Office of President Nelson Mandela in South Africa, in addition to serving as Minister of Telecommunications, Post, and Broadcasting. Mr. Naidoo has also served in several capacities as a member of the UN Advisory Committee on Information and Communication Technologies.
Top |
Back
Moises NAIM, Ph.D. – Editor and Publisher, Foreign Policy Magazine (Attended Summits 2005 & 2006)
Moises Naim, Ph.D., heads one of the world’s leading publications on international politics and economics. He has written extensively on the political economy of international trade and investment, multilateral organizations, economic reforms and globalization. Naim’s regular opinion columns appear in the Financial Times and are carried by many of the world’s leading newspapers. Naim previously served as Venezuela’s Minister of Trade and Industry.
Top |
Back
Yusuke NAKAMURA, M.D., Ph.D. – Chief Director, Human Genome Center, University of Tokyo (Attended Summit 2005)
Yusuke Nakamura, M.D., Ph.D., is the chief director of a laboratory that is studying the isolation of disease-related genes, such as cancer, through genomic analysis. He also is a professor in the Laboratory of Molecular Medicine at the University of Tokyo. Nakamura serves on the board for several nationally recognized publications, including Annals of Human Genetics, Cancer Research and Neoplasia. In 2000, he was awarded the Keio Medical Science Prize.
Top |
Back
Peter NEUPERT – Corporate Vice President of Health Strategy, Microsoft (Attended Summit 2006)
As corporate vice president for Health Strategy at Microsoft Corp., Peter Neupert is responsible for Microsoft’s collaboration with the healthcare ecosystem to address global infrastructure issues of significant scale. Before rejoining Microsoft, Mr. Neupert served as president and chief executive officer of Drugstore.com Inc. from July 1998 to April 2001, and then as chairman of the board of directors from July 1999 to September 2004. He served in various capacities at Microsoft from 1987 to 1998. He started at Microsoft as the director of operating systems responsible for shipping OS/2, and later was responsible for MSNBC as vice president of News and Publishing for the interactive media group. Mr. Neupert served on President Bush’s Information Technology Advisory Committee (PITAC) from 2003 to 2005. On that committee, he co-chaired the Health Information Technology subcommittee and helped drive the report “Revolutionizing Health Care Through Information Technology,” published in June 2004 by PITAC. In 2000, Neupert received an Ernst & Young Entrepreneur of the Year award for his work at Drugstore.com.
Top |
Back
Sam NUNN – Co-Chairman and Chief Executive Officer, Nuclear Threat Initiative (Attended Summit 2007)
Sam Nunn is Co-Chairman and CEO of the Nuclear Threat Initiative, an organization working to reduce the global threats from nuclear, biological, and chemical weapons. From 1972-1996, he served as U.S. Senator from Georgia where he was Chairman of the U.S. Senate Armed Services Committee among other Senate committees. Senator Nunn is a Professor in the Sam Nunn School of International Affairs at Georgia Tech and Chairman of the Board of the Center for Strategic and International Studies.
Top |
Back
O
Maynard OLSON, Ph.D. – Director, Genome Center and Professor of Medicine, Genome Science, University of Washington (Attended Summits 2005 & 2006)
Maynard Olson is Professor of Medicine and Genome Sciences and Director of the Genome Center at the University of Washington in Seattle. Though initially trained as a chemist, Dr. Olson made an early-career switch to genetics, where his research helped lay the technical foundations for the Human Genome Project. He participated in the sequencing of the human genome as both a scientist and an advisor to many institutions, including the National Institutes of Health and the Beijing Genome Center.
Top |
Back
Dennis O'LEARY – President, Joint Commision on Accreditation of Healthcare Organizations (JCAHO) (Attended Summit 2006)
Dennis O'Leary is President of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).
Top |
Back
Koji OMI – Former Minister of Finance and Chairman and Founder of Science and Technology in Society forum (Attended Summits 2005 & 2006, Confirmed for 2008)
Koji Omi serves as member of the House of Representatives and previously served as the director of the Ministry of International Trade and Industry Venture Capital Program and as Minister of State for Okinawa and Northern Territories Affairs. Koji Omi has encouraged international collaboration on science initiatives and has helped Japan to become a leader in science and technology by turning academic research into practical applications.
Top |
Back
P
Mark V. PAULY, Ph.D. – Bendheim Professor, Wharton School (Attended Summit 2005)
Mark V. Pauly is Bendheim Professor in the Department of Health Care Systems at the Wharton School of the University of Pennsylvania. He is Professor of Health Care Systems, Insurance and Risk Management, and Business and Public Policy at the Wharton School and Professor of Economics in the School of Arts and Sciences at the University of Pennsylvania. Dr. Pauly is a former commissioner on the Physician Payment Review Commission, a former member of the advisory committee to the Agency for Health Care Research and Quality, most recently a member of the Medicare Technical Advisory Panel, and an active member of the Institute of Medicine. He is a co-editor-in-chief of the International Journal of Health Care Finance and Economics and an associate editor of the Journal of Risk and Uncertainty.
Top |
Back
Steven PHILLIPS, M.D. – Chief Medical Officer, Exxon Mobil Corporation (Attended Summits 2005 & 2006)
Steven Phillips is the Chief Medical Officer for the Exxon Mobil Corporation.
Top |
Back
Barry M. POPKIN, Ph.D. - Director, Interdisciplinary Center for Obesity; Professor, Global Nutrition, University of North Carolina, Chapel Hill
Barry M. Popkin, PhD, is The Carla Smith Chamblee Distinguished Professor of Global Nutrition and Director of the University of North Carolina’s Interdisciplinary Center for Obesity. His research program focuses on understanding changes in dietary and physical activity behavior, underlying environmental causes, and their health consequences. He is active in a number of NIH-funded longitudinal studies around the world and chairs the Nutrition Transition Committee for the International Union for the Nutritional Sciences.
Top |
Back
John POTTER, M.D., Ph.D. – Senior Vice President and Director, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center (Attended Summits 2005, 2006, & 2007)
Dr. John D. Potter has been Director of Public Health Sciences at the Fred Hutchinson Cancer Research Center since 2002. As Professor of Epidemiology at University of Washington, Dr. Potter studies risk and intermediate biology in gastrointestinal cancer, and has an international reputation in nutrition, epidemiology, and studies of gene-environment interaction. He chaired the international panel producing the
1997 report: "Food, Nutrition, and the Prevention of Cancer". Dr. Potter’s research focuses on environmental determinants of microsatellite instability, NSAIDS, folate, and DNA repair in colon neoplasia.
Top |
Back
Franklyn PRENDERGAST, M.D., Ph.D. – Director, Cancer Research, Mayo Clinic (Attended Summit 2006)
Dr. Prendergast is the Director of the Mayo Clinic Comprehensive Cancer Research. He has published over 150 research papers, which include cutting edge research in the field of Biomedicine. His extensive involvement in numerous professional organizations and societies in the United States include The National Academy of Sciences, The National Cancer Advisory Board and the American Chemical Society. Dr Prendergast has also served for the past 14 years on the Board of Scientific Advisors for the National Cancer Institute.
Top |
Back
Q
You-Lin QIAO, M.D., M.P.H., Ph.D. – Professor and Chief, Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences (Attended Summit 2005)
Dr. Qiao is also a member of the Executive Council, China Cancer Research Foundation, and Deputy Director and Scientific Coordinator of the National Consortium of Cervical Cancer Prevention and Control. He is involved in many national and international projects to study etiology, primary intervention and early detection of variety cancers through multidisciplinary and global collaborations. As an expert in cancer prevention and control, he serves on several WHO Technical Advisory Groups and committees for promoting cancer prevention and control in developing countries.
Top |
Back
R
Regina RABINOVICH, M.D. – Director, Infectious Diseases, Bill & Melinda Gates Foundation (Attended Summits 2006 & 2007)
Regina Rabinovich directs the Infectious Diseases Division of the Bill & Melinda Gates Foundation’s Global Health Program, where she is involved in the development of strategies and their implementation for the prevention, treatment and control of diseases of particular relevance to global health, focusing on malaria, pneumonia, diarrhea, HPV, and the more classic “neglected diseases”. Dr. Rabinovich has served in various positions at NIAID, such as Chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases. During her tenure as branch chief, the units completed large multi-center trials of pertussis and influenza vaccines, as well as a number of phase I trials of platform technologies such as an edible vaccine, and vaccines for malaria and rotavirus. In 1999, she became director of the Malaria Vaccine Initiative, PATH. She also participated with WHO and the U.S. CDC in the creation of a project to develop a meningococcal vaccine to prevent epidemics in sub-Saharan Africa.
Top |
Back
Rino RAPPUOLI, Ph.D. – Global Head of Vaccines Research, Novartis Vaccines and Diagnostics (Attended Summit 2007)
Regina Rabinovich directs the Infectious Diseases Division of the Bill & Melinda Gates Foundation’s Global Health Program, where she is involved in the development of strategies and their implementation for the prevention, treatment and control of diseases of particular relevance to global health, focusing on malaria, pneumonia, diarrhea, HPV, and the more classic “neglected diseases”. Dr. Rabinovich has served in various positions at NIAID, such as Chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases. During her tenure as branch chief, the units completed large multi-center trials of pertussis and influenza vaccines, as well as a number of phase I trials of platform technologies such as an edible vaccine, and vaccines for malaria and rotavirus. In 1999, she became director of the Malaria Vaccine Initiative, PATH. She also participated with WHO and the U.S. CDC in the creation of a project to develop a meningococcal vaccine to prevent epidemics in sub-Saharan Africa.
Top |
Back
K. Srinath REDDY, M.D. – President, Public Health Foundation of India (Attended Summit 2007, Confirmed for 2008)
K. Srinath Reddy, MD, is President of the Public Health Foundation of India and until recently headed the Department of Cardiology at All India Institute of Medical Sciences. He has served on many WHO expert panels, and has edited the National Medical Journal of India for ten years. Dr. Reddy has won several prestigious awards including the WHO Director-General’s Award for Global Leadership in Tobacco Control in 2003.
Top |
Back
Sangita REDDY – Managing Director, Apollo Health Street, India (Attended Summits 2005 & 2006)
Sangita Reddy is the Managing Director of Apollo Health Street. Under her guidance, Apollo has become a leading offshore services firm and services some of the largest US payers and providers. Ms. Reddy has been a pioneer in advocating the benefits of the global delivery model and has helped clients in overcoming the unique challenges of working with an offshore vendor. In addition to her leadership role at Apollo Health Street, Ms. Reddy is also the Executive Director of the Apollo Hospitals group, the third largest for-profit hospital group in the world.
Top |
Back
Uwe REINHARDT, Ph.D. – James Madison Professor of Political Economy, Princeton University (Attended Summits 2005, 2006, & 2007, Confirmed for 2008)
Uwe Reinhardt, Ph.D., is one of the United States’ leading authorities on health care economics and policy. While a professor at Princeton University, he has served on a number of governmental committees and commissions and has been a member of editorial boards for medical journals. He is a member of the Council on the Economic Impact of Health Reform and serves on the Board of Advisors of the National Institute of Health-Care Management.
Top |
Back
S
Satku K. SATKUNANANTHAM, M.D. – Director of Medical Services, Ministry of Health, Singapore (Attended Summits 2005 & 2006)
Dr. Satku K. Satkunanantham is the Director of Medical Services, Ministry of Health, Singapore. He is also the Registrar of the Singapore Medical Council that regulates the medical profession. As an orthopedic surgeon, Dr. Satku continues to pursue his practice with an interest in knee surgery. His main goals in the Ministry are to promote translational research and structured teaching programmes for both medical undergraduates and postgraduates.
Top |
Back
Keith SCHORSCH – Founder and Chief Executive Officer, Peerwisdom (Attended Summit 2007)
Keith Schorsch is Founder and CEO of Peerwisdom, an Internet-based knowledge network connecting people to first-hand health experiences. Previously, he worked at Amazon in various senior general management, business development, and financial leadership roles. He has extensive experience in launching new businesses utilizing emerging technologies and led Amazon’s early strategic expansion plans. Since 2003, he has served on the Board of Trustees of the Fred Hutchinson Cancer Research Center.
Top |
Back
Haruo SHIMADA, Ph.D. – President, Chiba University of Commerce; Chairman, Economic Research Center, Fujitsu Research Center (Attended Summits 2005, 2006, & 2007)
Dr. Haruo Shimada is President of the Chiba University of Commerce and Chairman of the Economic Research Center of the Fujitsu Research Center. Dr. Shimada is one of the most active and outspoken economists in Japan. He was appointed Special Adviser to the Cabinet Officer and chairman of Economic Research Center Fujitsu Research Institute. Dr. Shimada is a member of the national tax commission, the fiscal system council, the Japan investment council, and the industrial structure council. He has written numerous books on Japanese economy, international management and labor problems. His expertise is in labor economics and industrial relations, international management and economic policies.
Top |
Back
Ian SHUGART – Senior Assistant Deputy Minister, Health Canada (Attended Summit 2006)
Ian Shugart is Senior Assistant Deputy Minister in the Health Policy Branch of Health Canada. He provides overall policy leadership in Health Canada, with a focus on health care reform, international health affairs, legislative renewal, and pharmaceutical issues. He chairs the Global Health Security Action Group, and the Health Task Force of APEC, and serves as a member of the Executive Board of the WHO. Previously, Mr. Shugart was the Visiting Assistant Deputy Minister in the Health Protection Branch.
Top |
Back
Greg SIMON, J.D. – President, FasterCures (Attended Summits 2005 & 2006)
Greg Simon is President of FasterCures, prior to which he was CEO of Simon Strategies/Mindbeam. From 1993 to 1997, he was Chief Domestic Policy Advisor to Vice President Al Gore specifically on economic, science and technology issues. In that capacity, he oversaw a number of initiatives, including the programs of the National Institutes of Health, National Cancer Institute, Food and Drug Administration (FDA), the Human Genome Project, and the development of the regulatory framework for biotechnology products. Simon played a leading role in a variety of White House policies and programs including passage of the Telecommunications Reform Act of 1996; encouraging the development a V-chip-compatible system of television ratings; the space program, particularly the building of the International Space Station; and FDA reform. From 1985 to 1991, Simon was the Staff Director of the Investigations and Oversight Subcommittee of the House of Representatives Committee on Science, Space and Technology.
Top |
Back
Peter A. SINGER, M.D. – Sun Life Financial Chair in Bioethics and Director, University of Toronto Joint Centre for Bioethics (Attended Summits 2005 & 2006, Confirmed for 2008)
Peter A. Singer is the Sun Life Financial Chair in Bioethics and Director of the University of Toronto Joint Centre for Bioethics. Additionally, he is Program Leader of the Canadian Program on Genomics and Global Health. Dr. Singer is a Distinguished Investigator of the Canadian Institutes of Health Research and a member of the Scientific Advisory Board of the Bill & Melinda Gates Foundation's Grand Challenges in Global Health initiative.
Top |
Back
Ralph SNYDERMAN, M.D. – Chancellor Emeritus, Duke University Health System (Attended Summit 2005)
Dr. Ralph Snyderman is Chancellor Emeritus of Duke University and James B. Duke Professor of Medicine in the Duke University School of Medicine. He served as Chancellor for Health Affairs and Dean of the School of Medicine from 1989 to July 2004. During this period, he oversaw the development of the Duke University Health System, one of the most successful integrated academic health systems in the country, and served as its President and CEO. Dr. Snyderman has played a leading role in the conception and development of Prospective Care, a novel approach to personalized health and an evolving model of national health delivery.
Top |
Back
Triono SOENDORO, M.D., Ph.D. – Director-General, National Institute of Health Research and Development, Ministry of Health, Indonesia (Attended Summit 2007)
Triono Soendoro, MD, PhD, is Director-General of the National Institute of Health Research and Development at the Ministry of Health in Indonesia. Previously, he was Director of Center for Education and Training at the Ministry of Health and has held other positions in the Indonesian government. He is also a Senior Associate and Gates Leadership Fellow at the Bill & Melinda Gates Institute for Population and Reproductive Health at Johns Hopkins University.
Top |
Back
Alfred SOMMER – Professor of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University (Attended Summit 2006)
Alfred Sommer is a professor of epidemiology and former dean at the Bloomberg School of Public Health at Johns Hopkins University. An international public health figure who has been honored by medical institutes and societies around the world, Dr. Sommer received both the prestigious Albert Lasker Clinical Medical Research Award and Switzerland’s Helmut Horten Medical Research Award for his discovery that inexpensive vitamin A could save the sight and lives of more than a million children in the developing world each year. His international work has focused on controlling malnutrition, infectious diseases, and blindness, and he and his family have lived for extended periods in Bangladesh, Indonesia, and the United Kingdom. Dr. Sommer’s publications include more than 250 articles as well as books and monographs. He has served on several boards and advisory groups for organizations such as the World Health Organization, the National Institutes of Health, and the National Academy of Sciences.
Top |
Back
Linda SONNTAG, Ph.D. - Founder, Equity Investment Partners, LP (Attended Summits 2005 & 2006)
Dr. Linda Sonntag is currently engaged in the founding of Equity Investment Partners, LP, (EQUIP) a Social Venture Fund for Global Health, in partnership with Social Equity Ventures, Inc. (SEV), a new nonprofit, PATH-controlled affiliate, to support the creation and operation of a venture capital fund focused on health technology solutions for developing-world markets. Most recently, Dr. Sonntag was a General Partner of Axiom Venture Partners, L.P., founded in April 1994 to invest primarily in medical/healthcare and media/communications areas.
Dr. Sonntag was the first woman CEO of a publicly held biotechnology company, SyStemix, Inc., and negotiated a $392MM investment in the company from Swiss drug giant Sandoz, now Novartis, for 60% of the common stock, at a firm value of $650 million. She has a Ph.D. in biochemistry from the University of Witwatersrand in South Africa.
Top |
Back
Kenneth STUART, Ph.D. - President and Director, Seattle Biomedical Research Institute (Attended Summits 2005, 2006, & 2007)
Dr. Stuart co-founded the Seattle Biomedical Research Institute in 1976, and serves as the first President and Director of the Institute. SBRI is the largest independent, non-profit organization in the United States focused solely on infectious disease research. The mission of SBRI's nearly 200 employees is to eliminate the world's most devastating infectious diseases through leadership in scientific discovery. SBRI's research targets the world's most underserved populations: the 14 million people who die each year from diseases such as malaria, HIV/AIDS and tuberculosis as well as other lesser known, but equally deadly diseases, including African sleeping sickness, Chagas disease and leishmaniasis. Dr.Stuart is a Professor of Pathobiology at the University of Washington, and served as Department Chair from 1996-2004. His research encompasses genomics and gene expression processes in three Trypanosomatid parasites that kill more than one million people each year. His research program has been supported by grants from NIH, WHO, and several foundations.
Top |
Back